Keyword Connections

•  Clarence Creech
•  Mark Denison

•  Pamela Hull
•  Thomas Talbot

Resources

• No matching connections

Communities

• No matching connections

Publications

• Risk of sudden infant death syndrome after immunization with the diphtheria-tetanus-pertussis vaccine.
  Griffin MR, Ray WA, Livengood JR, Schaffner W
  (1988) N Engl J Med 319: 618-23
• Transmission of Mycobacterium tuberculosis from health care workers.
  Sterling TR, Haas DW
  (2006) N Engl J Med 355: 118-21
• Intranasal influenzavirus vaccine in children.
  Edwards KM, Dupont WD
  (1998) N Engl J Med 339: 922; author reply 922-3
• Hospitalizations after a decade of pneumococcal vaccination.
  Griffin MR, Grijalva CG
  (2013) N Engl J Med 369: 1662-3
• Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
  Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF, IMPACT Study Investigators
  (2010) N Engl J Med 363: 411-22
• U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.
  Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG
  (2013) N Engl J Med 369: 155-63
• Improved survival with ipilimumab in patients with metastatic melanoma.
  Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbé C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ
  (2010) N Engl J Med 363: 711-23
• The underrecognized burden of influenza in young children.
  Poehling KA, Edwards KM, Weinberg GA, Szilagyi P, Staat MA, Iwane MK, Bridges CB, Grijalva CG, Zhu Y, Bernstein DI, Herrera G, Erdman D, Hall CB, Seither R, Griffin MR, New Vaccine Surveillance Network
  (2006) N Engl J Med 355: 31-40
• Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.
  Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR
  (2007) Lancet 369: 1179-86
• Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice.
  Sapparapu G, Fernandez E, Kose N, Bin Cao , Fox JM, Bombardi RG, Zhao H, Nelson CA, Bryan AL, Barnes T, Davidson E, Mysorekar IU, Fremont DH, Doranz BJ, Diamond MS, Crowe JE
  (2016) Nature 540: 443-447
• A proteomic view of the Plasmodium falciparum life cycle.
  Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, Haynes JD, Moch JK, Muster N, Sacci JB, Tabb DL, Witney AA, Wolters D, Wu Y, Gardner MJ, Holder AA, Sinden RE, Yates JR, Carucci DJ
  (2002) Nature 419: 520-6
• Proof of principle for epitope-focused vaccine design.
  Correia BE, Bates JT, Loomis RJ, Baneyx G, Carrico C, Jardine JG, Rupert P, Correnti C, Kalyuzhniy O, Vittal V, Connell MJ, Stevens E, Schroeter A, Chen M, Macpherson S, Serra AM, Adachi Y, Holmes MA, Li Y, Klevit RE, Graham BS, Wyatt RT, Baker D, Strong RK, Crowe JE, Johnson PR, Schief WR
  (2014) Nature 507: 201-6
• Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.
  Fox JM, Long F, Edeling MA, Lin H, van Duijl-Richter MKS, Fong RH, Kahle KM, Smit JM, Jin J, Simmons G, Doranz BJ, Crowe JE, Fremont DH, Rossmann MG, Diamond MS
  (2015) Cell 163: 1095-1107
• Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses.
  Joyce MG, Wheatley AK, Thomas PV, Chuang GY, Soto C, Bailer RT, Druz A, Georgiev IS, Gillespie RA, Kanekiyo M, Kong WP, Leung K, Narpala SN, Prabhakaran MS, Yang ES, Zhang B, Zhang Y, Asokan M, Boyington JC, Bylund T, Darko S, Lees CR, Ransier A, Shen CH, Wang L, Whittle JR, Wu X, Yassine HM, Santos C, Matsuoka Y, Tsybovsky Y, Baxa U, NISC Comparative Sequencing Program, Mullikin JC, Subbarao K, Douek DC, Graham BS, Koup RA, Ledgerwood JE, Roederer M, Shapiro L, Kwong PD, Mascola JR, McDermott AB
  (2016) Cell 166: 609-623
• Teaching a Clone to Walk, One Step at a Time.
  Crowe JE
  (2016) Cell 166: 1360-1361
• Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody.
  Bonsignori M, Zhou T, Sheng Z, Chen L, Gao F, Joyce MG, Ozorowski G, Chuang GY, Schramm CA, Wiehe K, Alam SM, Bradley T, Gladden MA, Hwang KK, Iyengar S, Kumar A, Lu X, Luo K, Mangiapani MC, Parks RJ, Song H, Acharya P, Bailer RT, Cao A, Druz A, Georgiev IS, Kwon YD, Louder MK, Zhang B, Zheng A, Hill BJ, Kong R, Soto C, NISC Comparative Sequencing Program, Mullikin JC, Douek DC, Montefiori DC, Moody MA, Shaw GM, Hahn BH, Kelsoe G, Hraber PT, Korber BT, Boyd SD, Fire AZ, Kepler TB, Shapiro L, Ward AB, Mascola JR, Liao HX, Kwong PD, Haynes BF
  (2016) Cell 165: 449-63
• Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody.
  Kong R, Xu K, Zhou T, Acharya P, Lemmin T, Liu K, Ozorowski G, Soto C, Taft JD, Bailer RT, Cale EM, Chen L, Choi CW, Chuang GY, Doria-Rose NA, Druz A, Georgiev IS, Gorman J, Huang J, Joyce MG, Louder MK, Ma X, McKee K, O'Dell S, Pancera M, Yang Y, Blanchard SC, Mothes W, Burton DR, Koff WC, Connors M, Ward AB, Kwong PD, Mascola JR
  (2016) Science 352: 828-33
• Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.
  Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, Wilson IA
  (2010) Science 328: 357-60
• Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination.
  Grijalva CG, Zhu Y, Williams DJ, Self WH, Ampofo K, Pavia AT, Stockmann CR, McCullers J, Arnold SR, Wunderink RG, Anderson EJ, Lindstrom S, Fry AM, Foppa IM, Finelli L, Bramley AM, Jain S, Griffin MR, Edwards KM
  (2015) JAMA 314: 1488-97
• Maternal pertussis immunization: can it help infants?
  Jiménez-Truque N, Edwards KM
  (2014) JAMA 311: 1736-7
• Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial.
  Talbot TR, Stapleton JT, Brady RC, Winokur PL, Bernstein DI, Germanson T, Yoder SM, Rock MT, Crowe JE, Edwards KM
  (2004) JAMA 292: 1205-12
• Risk of seizures and encephalopathy after immunization with the diphtheria-tetanus-pertussis vaccine.
  Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W
  (1990) JAMA 263: 1641-5
• A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease.
  Graham RL, Becker MM, Eckerle LD, Bolles M, Denison MR, Baric RS
  (2012) Nat Med 18: 1820-6
• Restraining the pneumococcus.
  Griffin MR, Grijalva CG
  (2015) Lancet Infect Dis 15: 491-2
• Assessing the effect of pneumococcal conjugate vaccines: what is the value of routinely collected surveillance data?
  Grijalva CG, Moore MR, Griffin MR
  (2011) Lancet Infect Dis 11: 724-6
• Decrease in antibiotic use, an added benefit of PCVs.
  Grijalva CG
  (2014) Lancet Infect Dis 14: 175-7
• Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop.
  Cale EM, Gorman J, Radakovich NA, Crooks ET, Osawa K, Tong T, Li J, Nagarajan R, Ozorowski G, Ambrozak DR, Asokan M, Bailer RT, Bennici AK, Chen X, Doria-Rose NA, Druz A, Feng Y, Joyce MG, Louder MK, O'Dell S, Oliver C, Pancera M, Connors M, Hope TJ, Kepler TB, Wyatt RT, Ward AB, Georgiev IS, Kwong PD, Mascola JR, Binley JM
  (2017) Immunity 46: 777-791.e10
• High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801.
  Kirkwood JM, Ibrahim JG, Sosman JA, Sondak VK, Agarwala SS, Ernstoff MS, Rao U
  (2001) J Clin Oncol 19: 2370-80
• When will melanoma vaccines be proven effective?
  Sosman JA, Weeraratna AT, Sondak VK
  (2004) J Clin Oncol 22: 387-9
• Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome.
  Sosman JA, Unger JM, Liu PY, Flaherty LE, Park MS, Kempf RA, Thompson JA, Terasaki PI, Sondak VK, Southwest Oncology Group
  (2002) J Clin Oncol 20: 2067-75
• Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology Group.
  Sondak VK, Liu PY, Tuthill RJ, Kempf RA, Unger JM, Sosman JA, Thompson JA, Weiss GR, Redman BG, Jakowatz JG, Noyes RD, Flaherty LE
  (2002) J Clin Oncol 20: 2058-66